Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Therapeutically active PTH derivatives reported by Takeda

Jan. 27, 1997

Phase I trials begin for Fabry's disease

Jan. 24, 1997

Muse licensed to Janssen for certain markets

Jan. 24, 1997

GelTex reports CholestaGel phase II data

Jan. 24, 1997

Positive phase II results reported for platelet substitute

Jan. 24, 1997

Additional beneficial lipid-modifying effects of FCP-3P1 reported

Jan. 24, 1997

Cerebrus discovers role of gene in obesity

Jan. 24, 1997

Inhibitors of alpha-amylase disclosed by Japanese researchers

Jan. 23, 1997

ACAT inhibitors from Takeda

Jan. 23, 1997

NESP enters clinical trials

Jan. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...